Objection to the Draft Commission Implementing Regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor (D067115-02)

Adopted

Reference: B9-0203/2020

Date: 09.07.2020

The Left in the European Parliament (GUE/NGL) Logo

GUE/NGLThe Left in the European Parliament (GUE/NGL)

13 Members

Group Voting Result

  • 12For
  • 0Against
  • 0Abstention
  • 1Did not vote

Majority of the group: For · no deviations

Majority = position with the most votes in the group; "Did not vote" does not count. In case of a tie there is no majority and no deviators.

Show filters
Follow us on Instagram@checksomevotes@checksomevotes_en